WHAT IS SEMAGLUTIDE?

Semaglutide is a diabetes medication used to control blood sugar. It may also reduce the risk of heart attack, stroke and other serious complications of type 2 diabetes or heart or blood vessel disease. It works by increasing the amount of insulin in your bloodstream, reducing the blood sugar levels of a person who has trouble regulating. Though semaglutide may be used to treat diabetes, it’s not insulin. It’s a medication that can be used to help insulin do its job and lower blood sugar, but most patients are advised to use it as part of a comprehensive approach to treat type 2 diabetes, in conjunction with diet and exercise and any other medication or dietary supplement their doctor has approved.

SEMAGLUTIDE FOR WEIGHT LOSS-

Originally developed as a treatment for type 2 diabetes, semaglutide has also found a niche helping people with weight-related medical problems rapidly lose weight. It does this in three ways:

1. The GLP-1 hormone present in the medication slows down how fast your stomach moves food through, which makes you feel fuller longer and discourages binge eating.

2. The hormone prevents the liver from releasing sugar into the bloodstream, which would otherwise contribute to fat buildup.

3. Semaglutide stimulates the pancreas to secrete insulin, reducing blood sugar still more.

When used for treating obesity, semaglutide should always be paired with improved diet and a regular healthy exercise program. Subcutaneous semaglutide, a brand name of semaglutide was subjected to four separate placebo controlled trials lasting 68 weeks. The testing showed that medication was more effective than the placebo for weight loss and chronic weight management. For people with weight-related medical problems, semaglutide can be an effective choice for helping lose weight, advance a successful weight loss program and maintain a healthy body weight for as long as the treatments are given.

IS SEMAGLUTIDE SAFE?

The FDA first approved semaglutide to help people lose weight in 2021, making it the first anti-obesity medication to be allowed onto the market since 2014. When used for treating obesity, the medication should always be paired with improved diet and a regular healthy exercise program. Subcutaneous semaglutide, a brand name of  semaglutide was subjected to four separate placebo controlled trials lasting 68 weeks. The testing showed that medication was more effective than the placebo for weight loss and chronic weight management

​

 

 

​

 

​

 

​

​

​

​

 

​